Monday, 06 December 2021 08:37 GMT

Central Petroleum Limited (ASX:CTP) ACCC Approves Joint Marketing


(MENAFN- ABN Newswire)
ACCC Approves Joint Marketing Brisbane, Mar 2, 2018 AEST (ABN Newswire) - Central Petroleum Limited () () ("the Company" or "Central") has been advised by the ACCC this morning that:

1) the ACCC has today published a draft determination proposing to grant authorisation for Mereenie joint marketing subject to the following conditions:

- a 3 year time limit (in which gas supply agreements can be collectively negotiated); and

- a time limit of 31 December 2028 on the term of gas supply agreement that are sol collectively negotiated.

2) the ACCC will today publish a determination to grant interim authorisation, such that it will be possible for the applicants to proceed to collectively negotiate immediately from that decision (subject to any gas supply agreements being conditional on final grant of authorisation and the conditions proposed for authorisation as noted above).

Central will convene a joint venture meeting as quickly as possible to seek approval of the joint venture to allow the drilling at West Mereenie-26 to go ahead as scheduled, as well as the plant upgrade aimed at increasing processing capacity to around 63 TJ/d gross, of which 4 TJ/d will be used as fuel gas.


About Central Petroleum Limited

()() is an oil and gas explorer and producer listed on the Australian Securities Exchange focused on supplying the domestic gas market. Central is advancing several separate projects across what is regarded as the biggest package of proven and prospective oil and gas acreage across central Australia. This spread of assets gives Central multiple options for growth and development. 88% of this land being gas prone has led to the Company's focus on becoming a major domestic gas producer.


MENAFN0103201801110000ID1096536619


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.